Thermo Fisher Scientific Inc.TMONYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank10
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P10
Near historical low
vs 5Y Ago
-2.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -16.41% |
| Q3 2025 | 32.94% |
| Q2 2025 | -13.77% |
| Q1 2025 | 13.04% |
| Q4 2024 | -12.30% |
| Q3 2024 | -7.39% |
| Q2 2024 | 3.74% |
| Q1 2024 | 32.48% |
| Q4 2023 | -19.81% |
| Q3 2023 | -4.85% |
| Q3 2023 | 0.42% |
| Q2 2023 | 19.82% |
| Q4 2022 | -19.52% |
| Q4 2022 | -2.94% |
| Q3 2022 | 0.09% |
| Q2 2022 | 22.54% |
| Q4 2021 | -4.42% |
| Q4 2021 | 0.21% |
| Q3 2021 | 7.24% |
| Q2 2021 | 1.91% |
| Q4 2020 | 7.83% |
| Q3 2020 | -1.26% |
| Q2 2020 | 7.96% |
| Q1 2020 | 28.75% |
| Q4 2019 | -20.27% |
| Q3 2019 | 0.13% |
| Q2 2019 | 0.87% |
| Q1 2019 | 28.89% |
| Q4 2018 | -20.98% |
| Q3 2018 | -3.24% |
| Q2 2018 | 2.44% |
| Q1 2018 | 31.06% |
| Q4 2017 | -16.02% |
| Q3 2017 | 6.83% |
| Q3 2017 | -1.50% |
| Q2 2017 | 1.42% |
| Q4 2016 | 3.67% |
| Q4 2016 | 22.14% |
| Q3 2016 | 0.05% |
| Q2 2016 | 2.39% |